Examples of using Were randomised in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
A total of 820 patients were randomised.
Totalt 820 pasienter ble randomisert.Patients were randomised to the two arms.
Pasienter ble randomisert til de to armene.In GS-US-205-0110, 268 patients with CF andchronic P. aeruginosa lung infection were randomised and received Cayston(n 136) or TNS n 132.
I GS-US-205-0110 ble 268 pasienter med CF ogkronisk P. aeruginosa lungeinfeksjon randomisert og fikk Cayston(n=136) eller TNS n=132.Patients were randomised to 1 of 4 treatment groups.
Pasienter ble randomisert til 1 av 4 behandlingsgrupper.In all studies, patients who did not respond to placebo during a 4-week placebo run-in phase were randomised to receive the study treatment.
I alle studiene ble pasienter som ikke responderte på placebo under en 4-ukers run-in fase, randomisert til å få studiebehandlingen.
People also translate
Patients were randomised to bolus 5-FU and leucovorin.
Pasienter ble randomisert til bolus 5-FU og leukovorin.A total of 358 patients were randomised and treated.
Totalt 358 pasienter ble randomisert og behandlet.Patients were randomised to NPWT or standard moist wound healing.
Pasientene ble randomisert til NPWT eller standardbehandling av fuktige sår.In a subsequent study, 217 patients who were treatment-naïve to PDE5 inhibitors were randomised to tadalafil 5 mg once a day vs. placebo.
I en senere studie ble 217 pasienter som var behandlingsnaive til PDE5-inhibitorer randomisert til tadalafil 5 mg èn gang daglig versus placebo.Patients were randomised to placebo, ADASUVE 4.5 mg and ADASUVE 9.1 mg.
Pasientene ble randomisert til placebo, ADASUVE 4,5 mg og ADASUVE 9,1 mg.In study MV17150,patients who were non-responders to previous therapy with pegylated interferon alfa-2b plus ribavirin were randomised to four different treatments.
I studie MV17150, ble pasienter somvar non-respondere ved tidligere behandling med pegylert interferon alfa-2b pluss ribavirin randomisert til fire ulike behandlinger.A total of 452 patients were randomised to receive either.
Totalt 452 pasienter ble randomisert til å motta enten.Patients were randomised to receive placebo, Simponi 50 mg, or Simponi 100 mg.
Pasientene ble randomisert til å få placebo, Simponi 50 mg eller Simponi 100 mg.Twenty-three patients with newly diagnosed nocturnal hypoventilation due to chronic obstructive orrestrictive lung disease were randomised to iVAPS or standard PS for one month.
Tjuetre pasienter med nydiagnostisert nattlig hypoventilasjon på grunn av kronisk obstruktiv ellerrestriktiv lungesykdom var randomisert for iVAPS eller standard PS i en måned.Patients were randomised 2:1 to Jakavi versus best available therapy.
Pasientene ble randomisert 2:1 til Jakavi versus beste tilgjengelige behandling.The mean change from baseline at week 104 in total Sharp-Genant score was significantly lower for patients randomised to tocilizumab 8 mg/kg plus MTX(p< 0.0001)compared with patients who were randomised to placebo plus MTX.
Den største endringen fra utgangspunktet ved uke 104 i total”Sharp-Genant score” A total of 675 patients were randomised to vemurafenib(n=337) or dacarbazine n=338.
Totalt 675 pasienter ble randomisert til vemurafenib(n=337) eller dakarbazin n=338.Patients were randomised to either dexamethasone or placebo in addition to their assigned treatment.
Pasientene ble randomisert til deksametason eller placebo i tillegg til tildelt behandling.In a 6 week study 129 patients with mixed hyperlipidaemia were randomised to fenofibrate 160 mg plus 3.8 g Cholestagel or fenofibrate alone.
I en 6-ukers studie ble 129 pasienter med blandet hyperlipidemi randomisert til å få fenofibrat 160 mg, pluss 3,8 g Cholestagel eller kun fenofibrat.Patients were randomised 1:1 to receive 6 mg lipegfilgrastim or 6 mg pegfilgrastim.
Pasientene ble randomisert 1:1 for å få 6 mg lipegfilgrastim eller 6 mg pegfilgrastim.Eight hundred and twenty-nine patients were randomised 292 FOLFOX-4, 293 Avastin+ FOLFOX-4 and 244 Avastin monotherapy.
Åttehundreogtjueni pasienter ble randomisert 292 FOLFOX-4, 293 Avastin+ FOLFOX-4 og 244 Avastin som monoterapi.Patients were randomised to receive trastuzumab emtansine 3.6 mg/kg intravenously every 3 weeks(n= 67) or trastuzumab 8 mg/kg intravenous loading dose followed by 6 mg/kg intravenously every 3 weeks plus docetaxel 75-100 mg/m2 intravenously every 3 weeks(n= 70).
Pasientene var randomisert for å motta trastuzumab emtansin 3,6 mg/kg intravenøst hver 3. uke(n= 67) eller trastuzumab 8 mg/kg intravenøst oppstartsdose etterfulgt av 6 mg/kg intravenøst hver 3. uke pluss docetaksel 75-100 mg/ m2 intravenøst hver 3. uke(n= 70).A total of 519 patients were randomised to a treatment group: 259 to SPRYCEL and 260 to imatinib.
Totalt 519 pasienter ble randomisert til en behandlingsgruppe: 259 til SPRYCEL og 260 til imatinib.Both studies were randomised, double-blind, active-control studies in which infants were randomised to receive either Prevenar or control vaccine(NCKP, meningococcal serogroup C CRM-conjugate[MnCC] vaccine; FinOM, hepatitis B vaccine) in a four-dose series at 2, 4, 6, and 12-15 months of age.
Begge studiene var randomiserte, dobbeltblindede, aktiv-kontrollerte studier der spedbarn ble We included seven studies, four of which were randomised controlled trials, two non-randomised controlled studies and one controlled before and after study.
Vi inkluderte syv studier, hvorav fire randomiserte kontrollerte studier, to ikke-randomiserte kontrollerte studier og en kontrollert før- og etterstudie.They were randomised(2:1) to either dasatinib(70 mg twice daily) or imatinib 400 mg twice daily.
De ble randomisert(2:1) til enten dasatinib(70 mg to ganger daglig) eller imatinib 400 mg to ganger daglig.A total of 991 patients were randomised to trastuzumab emtansine or lapatinib plus capecitabine as follows.
Totalt 991 pasienter var randomisert til trastuzumab emtansin eller lapatinib pluss kapecitabin som følger.Patients were randomised to one of five treatment groups tadalafil 2.5 mg, 10 mg, 20 mg, 40 mg, or placebo.
Pasientene ble randomisert til en av fem behandlingsgrupper tadalafil 2,5 mg, 10 mg, 20 mg, 40 mg eller placebo.The two primary safety studies were randomised, active-controlled trials that enrolled participants aged 11 to 55 years(N=2663) and 19 to 55 years(N=1606).
De to primære sikkerhetsstudiene var randomiserte studier med aktiv kontroll som inkludert forsøkspersoner i alderen 11 til 55 år(N 2663) og 19 til 55 år N 1606.Patients were randomised to receive Simponi 50 mg, Simponi 100 mg or placebo administered subcutaneously every 4 weeks.
Pasientene ble randomisert til å få Simponi 50 mg, Simponi 100 mg, eller placebo administrert subkutant hver 4. uke.
